The insect protein industry has experienced a succession of high-profile setbacks in recent months. Ÿnsect entered liquidation in December 2025, Agronutris faced court-supervised restructuring in September 2026, and German producer FarmInsect announced it was winding down in September 2026. These failures have raised questions about whether the sector overestimated the speed of customer adoption or underestimated production costs.
During an interview with Expana this week at EuroTier 2026, leading insect protein provider Innovafeed executives addressed the industry’s recent bankruptcies and explained why their business model has proven more durable than those of some of their rivals.
Roel Boersma, Product Strategy & Marketing Director at Innovafeed, attributed the failures to fundamental mistakes in the scaling process. “As it is a new industry some make the right decisions and others don’t. It’s all about the balancegetting to the right cost level and finding the right price point,” Boersma said.
Maye Walraven, Chief Business and Impact Officer, argued that you need economies of scale, especially in Europe, that different insect protein business models work better in different geographies, and emphasized that the insect protein industry is still in its infancy.
Innovafeed’s own progress in Europe provides a case study in disciplined scaling, according to Walraven and Boersma. This year, the company completed its industrialization phase at its facility in Nesle, France, producing more than 15,000 tons of protein and oil over three years while increasing production volumes tenfold and reducing production costs by a factor of seven. In June, Innovafeed raised €51 million to support commercial acceleration and product innovation, demonstrating investor confidence in the company’s approach.
Innovafeed aims to reach 10,000 tons annually next year. Critically, the company has achieved a balance where production costs now align with market pricing. “We now have our production costs align with price and our investors see this within the context of the industry and the progress made by us,” Walraven said.
Part of Innovafeed’s competitive advantage also stems from operational efficiencies built into its model. The company has feedstock and energy sources nearby, reducing fixed costs, and splits energy expenses with neighboring operations. Additionally, Innovafeed does not transport wet product for drying, a costly practice that burdened some competitors.
And as production volumes increased, Innovafeed said it has also stabilized product quality and shifted focus toward functional components of the insect protein beyond basic protein content. “We can now use that additional knowledge and see a lot better where insect has a insect protein has a role to play in animal feed,” Walraven said.
A shift in Innovafeed’s commercial strategy also differentiates the company from failed competitors. Rather than pursuing a push model focused on securing massive volumes upfront, Innovafeed now emphasizes demonstrating product performance to drive organic demand.
“We’ve changed our approach securing huge volumes as it’s trickier to generate growth from that. Now we’re showing more the functionalities like FCR and growth and we adapt our volumes accordingly, following customer demand. Product performance is actually what is pushing demand and so that’s a step by step process and it’s a more organic process and a better fit with our own capacity,” Walraven said, adding that the venture capital model with a desire for return on investment in a short period of time, as seen in the sector in the past, is not necessarily compatible with the way the insect feed industry functions and needs to scale up.
Meanwhile, in North America, Innovafeed operates differently given the market environment. The company inaugurated its North American Insect Innovation Center in Decatur, Illinois, in April 2024 in collaboration with ADM, utilizing by-products from ADM’s corn wet mill to produce insect protein. However, plans for a full industrial facility remain on hold, Walraven told Expana.
“In the US we have a pilot plant and we’re happy with the quality of the product’s performance. The decision to build an industrial site is still on hold and maybe for the few next years. There have been financial constraints, and we have had a focus and profitability first, and there have also been the changes in the US political landscape in the last few years. Furthermore, Americans are a little more reluctant than Europeans when it comes to insect protein,” she said, adding that the company still has a very good partnership with ADM, which was extended from pet ingredients to aqua ingredients this year.
Innovafeed’s leadership projects confidence moving forward.
Boersma noted the company now has operational history and established customer relationships that provide greater certainty. “We’re at a grown up stage now and we have a bit of history behind us and some customer journeys so we’re more confident now than perhaps we were five years ago,” Boersma said.
Walraven acknowledged that ambitions had been “revised a bit” but stressed that adjusting expectations aligns with operational realities. “The new partnerships are in place and the industry now has more proof that we can be a consistent supplier,” she said.
Written by Simon Duke